These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10229104)

  • 21. The ins and outs of MHC class II-mediated antigen processing and presentation.
    Roche PA; Furuta K
    Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquisition of functional MHC class II/peptide complexes by T cells during thymic development and CNS-directed pathogenesis.
    Walker MR; Mannie MD
    Cell Immunol; 2002; 218(1-2):13-25. PubMed ID: 12470610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
    Tsang JY; Chai JG; Lechler R
    Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y; Watts TH
    J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cells.
    Marsh EW; Dalke DP; Pierce SK
    J Exp Med; 1992 Feb; 175(2):425-36. PubMed ID: 1310101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules.
    Barroso M; Tucker H; Drake L; Nichol K; Drake JR
    J Biol Chem; 2015 Nov; 290(45):27101-27112. PubMed ID: 26400081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-presenting hybridoma cells expressing MHC antigens of the LEW rat.
    Matsuda C; Yokota A; Izumi T; Shinohara N
    J Immunol Methods; 2001 May; 251(1-2):93-100. PubMed ID: 11292485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective elimination of antigen-specific line T cells and ex vivo antigen-primed lymph node cells by antigen-targeted drug-labeled antigen-presenting cell membranes.
    Chang NH; Boggs JM
    Cell Immunol; 1997 Mar; 176(2):135-45. PubMed ID: 9073386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II-mediated antigen presentation by melanoma cells.
    Brady MS; Eckels DD; Ree SY; Schultheiss KE; Lee JS
    J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):387-97. PubMed ID: 9041456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
    Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
    J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders.
    Mannie MD; Walker MR
    J Leukoc Biol; 2001 Aug; 70(2):252-60. PubMed ID: 11493617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse.
    Hiltbold EM; Poloso NJ; Roche PA
    J Immunol; 2003 Feb; 170(3):1329-38. PubMed ID: 12538693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.
    Colledge L; Bennett CL; Reay PA; Blackburn CC
    Eur J Immunol; 2002 Nov; 32(11):3246-55. PubMed ID: 12555670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of major histocompatibility complex restriction in the interaction between processed basic protein and Ia of two rat strains.
    Friedman A; Lider O; Beraud E; Cohen IR
    Scand J Immunol; 1989 Jun; 29(6):747-50. PubMed ID: 2787050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of membrane molecules from T cells endows antigen-presenting cells with novel functional properties.
    Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Peters PJ; Gadella BM; van Eden W; Wauben MH
    Eur J Immunol; 2004 Nov; 34(11):3115-25. PubMed ID: 15459903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.